- Home
- Signaling Pathways
- Neuroscience
- COX
- Aspirin (Acetylsalicylic acid)
Aspirin (Acetylsalicylic acid)
Aspirin (Acetylsalicylic acid) is a potent and selective inhibitor of cyclooxygenase (COX) with a broad range of pharmacological activities including anti-inflammation and pain relief. Multiple studies have accumulated sufficient evidence to establish the association between the use of aspirin and a reduced risk of cancers including prostate cancer, breast cancer, colorectal cancer, endometrial cancer, and ovarian cancer. Aspirin suppresses ovarian cancer cells harboring COX-1 by acting as histone deacetylase inhibitors to up-regulate cell cycle arrest protein p21. Aspirin also inhibits the expression of COX-2 in human umbilical vein endothelial cells and neonatal rat ventricular cardiomyocytes resulting in reduced PG production and the down-regulation of ERK and NF-KB respectively.
Reference
Cho M, Kabir SM, Dong Y, Lee E, Rice VM, Khabele D, Son DS. Aspirin Blocks EGF-stimulated Cell Viability in a COX-1 Dependent Manner in Ovarian Cancer Cells. J Cancer. 2013;4(8):671-678.
Duan Y, Chen F, Zhang A, Zhu B, Sun J, Xie Q, Chen Z. Aspirin inhibits lipopolysaccharide-induced COX-2 expression and PGE2 production in porcine alveolar macrophages by modulating protein kinase C and protein tyrosine phosphatase activity. BMB Rep. 2013. pii: 2320. [Epub ahead of print]
Storage | Store at -20°C |
M.Wt | 180.16 |
Cas No. | 50-78-2 |
Formula | C9H8O4 |
Synonyms | 2-Acetoxybenzoic acid, Acylpyrin, Ecotrin, Acenterine, Polopiryna, Acetosal |
Solubility | insoluble in H2O; ≥104.2 mg/mL in EtOH with ultrasonic; ≥8.55 mg/mL in DMSO |
Chemical Name | 2-acetyloxybenzoic acid |
SDF | Download SDF |
Canonical SMILES | CC(=O)OC1=CC=CC=C1C(=O)O |
Shipping Condition | Small Molecules with Blue Ice, Modified Nucleotides with Dry Ice. |
General tips | We do not recommend long-term storage for the solution, please use it up soon. |
Cell experiment:[1] | |
Cell lines |
Porcine alveolar macrophages |
Reaction Conditions |
3 mM aspirin for 30 min pretreatment |
Applications |
Aspirin inhibited lipopolysaccharide-induced COX-2 expression and PGE2 production in porcine alveolar macrophages by modulating protein kinase C and protein tyrosine phosphatase activity. |
Animal experiment:[2] | |
Animal models |
Male albino Charles River rats weighing between 200 and 250 g |
Dosage form |
5, 25, 50, 100 and 150 mg/kg Administered orally |
Applications |
Aspirin, administered orally at 5, 25, 50 and 100 mg/kg, exhibited antipyretic activity at all doses. The ED50 values calculated from these data ranged from 10.3 to 21.1 mg/kg. In addition, statistically significant antipyresis was demonstrated 15 min after an oral dose of 150 mg/kg of aspirin, with the maximum effect occurred at 120 min. |
Note |
The technical data provided above is for reference only. |
References: 1. Duan Y, Chen F, Zhang A, et al. Aspirin inhibits lipopolysaccharide-induced COX-2 expression and PGE2 production in porcine alveolar macrophages by modulating protein kinase C and protein tyrosine phosphatase activity. BMB Reports, 2014, 47(1): 45-50. 2. Loux JJ, DePalma PD, Yankell SL. Antipyretic testing of aspirin in rats. Toxicology and Applied Pharmacology, 1972, 22(4): 672-675. |
Quality Control & MSDS
- View current batch: